Coronary Artery Disease

BOSTON — At a median follow-up of 11.8 years, most outcomes did not differ between PCI with an everolimus-eluting stent and CABG in patients with multivessel CAD, according to new data from the BEST trial.

BOSTON — Ultrasound-guided femoral access improved first attempt success in coronary procedures but did not reduce the occurrence of major bleeding and vascular complications vs. fluoroscopy alone, a speaker reported.

PET with a novel radiotracer met its primary endpoint for sensitivity and specificity of CAD detection, researchers reported at the Annual Scientific Session and Exhibition of the American Society of Nuclear Cardiology.

Among patients with CAD, P2Y12 monotherapy was superior to aspirin monotherapy for prevention of CV death, MI and stroke, according to an individual patient data meta-analysis presented at the European Society of Cardiology Congress.

In patients with severe left ventricular systolic dysfunction on optimal medical therapy for HF, undergoing PCI did not improve rates of all-cause death or HF hospitalization, according to the results of the REVIVED-BCIS2 trial.

A combined monogenic and polygenic risk assessment for CAD can identify individuals at high inherited risk before overt manifestation of traditional risk factors, potentially improving clinician decision-making on preventive interventions.

180-day survival rate of patients with out-of-hospital cardiac arrest after emergency vs. delayed coronary angiogram.

PHILADELPHIA — Coronary artery calcium scoring is a helpful tool in patients aged 40 years or older whom a decision to start therapy for primary CVD prevention is not obvious, a speaker said at the Heart in Diabetes CME conference.

Among veterans who underwent post-elective PCI stress testing before the guideline-recommended 2 years due to chest pain, most had symptoms consistent with obstructive CAD, according to data published in JAMA Network Open.

Performing an emergency vs. delayed coronary angiogram after out-of-hospital cardiac arrest without ST segment elevation was not associated with greater 180-day survival rate or better neurologic outcomes, data from a randomized trial show.